Search

for
Search:

GlossaryEtanercept

biologic drug inhibiting TNF to reduce inflammation in autoimmune diseases

Etanercept is a biologic medication that works by inhibiting tumor necrosis factor (TNF), a substance in the body that causes inflammation. It is commonly used to treat autoimmune conditions like rheumatoid arthritis and psoriasis, where the immune system mistakenly attacks the body's own tissues.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 374 results

research Brazilian Experience of Treating Alopecia Universalis with Novel Antirheumatic Therapy Tofacitinib: A Case Series

16 citations , July 2017 in “Rheumatology and Therapy”

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

research Successful Etanercept Therapy in Therapy-Refractory Acrodermatitis Continua Suppurativa Hallopeau

20 citations , May 2007 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft”

Etanercept effectively treated a severe skin condition when other treatments failed.

Ixekizumab Shows Efficacy and Safety in Patients Who Failed Biweekly Etanercept Therapy: Analysis From UNCOVER-2, a Phase 3 Randomized Clinical Trial in Psoriasis

research Ixekizumab Shows Efficacy and Safety in Patients Who Failed Biweekly Etanercept Therapy: Analysis From UNCOVER-2, a Phase 3 Randomized Clinical Trial in Psoriasis

April 2016 in “Journal of The American Academy of Dermatology”

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

research Biologic: A Double-Edged Sword - A Case of Etanercept-Induced Alopecia Areata in a Patient with Psoriasis Vulgaris

January 2018 in “SOJ microbiology & infectious diseases”

Etanercept, a psoriasis treatment, caused hair loss in a patient.

research Innovative Therapeutics in Pediatric Dermatology

8 citations , May 2010 in “Dermatologic clinics”

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

View more "etanercept" in research →

Community Join

1 / 1 results

community Rejected for the 2nd time for the VDPHL01 Clinical Trials (believe it or not!)

in Chat 12 upvotes 11 months ago

The user was rejected from participating in a clinical trial for an extended-release oral Minoxidil due to having rheumatoid arthritis, despite initially being accepted. They had stopped using Dutasteride and Minoxidil to qualify but continued using other treatments like RU58841 and red light therapy.